athenahealth (ATHN) Receives “Market Perform” Rating from William Blair
A number of other brokerages also recently weighed in on ATHN. BidaskClub downgraded athenahealth from a hold rating to a sell rating in a research note on Wednesday, July 25th. Cowen restated a hold rating and issued a $150.00 target price on shares of athenahealth in a research note on Wednesday, August 1st. Canaccord Genuity boosted their target price on athenahealth from $125.00 to $160.00 and gave the stock a hold rating in a research note on Tuesday, July 31st. Stifel Nicolaus restated a hold rating and issued a $140.00 target price (up previously from $134.00) on shares of athenahealth in a research note on Tuesday, July 31st. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $145.00 price objective on shares of athenahealth in a research note on Tuesday, September 18th. One investment analyst has rated the stock with a sell rating, eighteen have issued a hold rating and three have assigned a buy rating to the company. athenahealth currently has an average rating of Hold and a consensus target price of $149.05.
Shares of NASDAQ ATHN opened at $131.63 on Monday. athenahealth has a twelve month low of $116.77 and a twelve month high of $163.94. The company has a market capitalization of $5.35 billion, a PE ratio of 83.84, a price-to-earnings-growth ratio of 2.33 and a beta of 0.80. The company has a current ratio of 2.74, a quick ratio of 2.62 and a debt-to-equity ratio of 0.22.
In related news, insider Daniel P. Haley sold 2,204 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $127.23, for a total value of $280,414.92. Following the transaction, the insider now owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last quarter, insiders sold 2,654 shares of company stock worth $340,770. 2.90% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the business. Kaizen Advisory LLC bought a new stake in athenahealth during the 3rd quarter valued at $886,000. Morgan Stanley raised its holdings in athenahealth by 0.6% during the 2nd quarter. Morgan Stanley now owns 4,565,845 shares of the health services provider’s stock valued at $726,608,000 after acquiring an additional 25,304 shares during the period. Point72 Asset Management L.P. bought a new stake in athenahealth during the 2nd quarter valued at $8,514,000. Oppenheimer & Co. Inc. raised its holdings in athenahealth by 37.5% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 3,029 shares of the health services provider’s stock valued at $482,000 after acquiring an additional 826 shares during the period. Finally, Parkside Investments LLC bought a new stake in athenahealth during the 2nd quarter valued at $318,000.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Read More: What is the Dividend Aristocrat Index?
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.